Trial Profile
Effect of Implantable Progestin-only Contraception on the Incidence of Type 2 Diabetes and Metabolic Syndrome in Thai Women With History of Gestational Diabetes
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2022
Price :
$35
*
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 20 Aug 2018 Planned End Date changed from 1 Mar 2016 to 1 Jun 2022.
- 20 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Jul 2015 Planned End Date changed from 1 Mar 2021 to 1 Mar 2016, according to ClinicalTrials.gov record.